Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia

Bone Marrow Transplantation

Volumn 49, Issue 11, 2014, Pages 1376-1381

  Lucarelli, G ^a   Isgro A ^a   Sodani, P ^a   Marziali, M ^a   Gaziev, J ^a   Paciaroni, K ^a   Gallucci, C ^a   Cardarelli, L ^a   Ribersani, M ^a   Alfieri, C ^a   De Angelis, G ^a   Armiento, D ^a   Andreani, M ^a   Testi, M ^a   Amato, A ^b   Akinyanju, O O ^c   Wakama, T T ^d  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b Centro Studi Microcitemie   (Italy)

^c Sickle Cell Foundation of Nigeria   (Nigeria)

^d NATIONAL HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CD34 ANTIGEN; CIDOFOVIR; COTRIMOXAZOLE; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS; VALPROIC ACID;

ACUTE CHEST SYNDROME; ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BLACK PERSON; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; DONOR; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLIOSIS; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HERPES VIRUS INFECTION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAIN; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; SCHOOL CHILD; SEIZURE; SEROLOGY; SIBLING; SICKLE CELL ANEMIA; SURVIVAL PREDICTION; VIRUS REACTIVATION; ADULT; ALLOGRAFT; ANEMIA, SICKLE CELL; ETHNOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLOGRAFTS; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; RETROSPECTIVE STUDIES; SIBLINGS; SURVIVAL RATE;

EID: 84909981898     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.167     Document Type: Article

References (23)

1. Thomas ED. Marrow transplantation for thalassemia. Lancet 1982; 2: 227-229.
2. Lucarelli G. Bone marrow transplantation in thalassemia. J Exp Clin Cancer Res 1983; 3: 313-315.
3. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008; 22: 53-63.
4. Sodani P, Gaziev J, Polchi P, Erer B, Giardini C, Angelucci E et al. New approach for bone marrow transplantation in patients with class. 3. thalassemia aged younger than. thalassemia aged younger than. 17. years. Blood 2004; 104: 1201-1203.
5. Roseff SD. Sickle cell disease: a review. Immunohematology 2009; 25: 67-74.
6. Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V et al. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. New Engl J Med 1984; 312: 880-884.
7. Nagel RL, Steinberg MH. Genetics of the s gene: origins, epidemiology, and epistasis. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Steinberg MH, Forget BG, Higgs DR, Nagel RL (eds). Cambridge University Press: Cambridge, 2001, pp 711-755.
8. Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol 2012; 87: 795-803.
9. Lucarelli G, Gaziev J, Isgrò A, Sodani P, Paciaroni K, Alfieri C et al. Allogeneic cellular gene therapy in hemoglobinopathies: evaluation of hematopoietic stem cell transplantation in Sickle Cell Anemia. Bone Marrow Transplant 2012; 47: 227-230.
10. Amato A, Cappabianca MP, Colosimo A, Perri M, Grisanti P, Zaghis I et al. Current genetic epidemiology of beta-thalassemias and structural hemoglobin variants in the Lazio Region (Central Italy) following recent migration movements. Adv Hematol 2010; 2010: 317542.
11. Gaziev J, Nguyen L, Puozzo C, Mozzi AF, Casella M, Perrone Donnorso M et al. Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring. Blood 2010; 115: 4597-4604.
12. Bullard WG, Romanoff ME, Woodward DG. Risk factors associated with sickle cell trait. AANA J 1989; 57: 101.
13. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
14. Giardini C. Bone marrow transplantation in sickle cell disorders in Pesaro. Bone Marrow Transplant 1997; 19: 106-109.
15. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC et al. Bone marrow transplantation for sickle cell disease. New Engl J Med 1996; 335: 369-376.
16. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first. 50. patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1-6.
17. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110: 2749-2756.
18. Majumdar S., Robertson Z., Robinson A., Starnes S., Iyer R., Megason G. Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience. Bone Marrow Transplant 2010; 45: 895-900.
19. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137-2143.
20. Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP et al. Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007; 137: 479-485.
21. McPherson ME, Hutcherson D, Olson E, Haight AE, Horan J, Chiang KY et al. Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease. Bone Marrow Transplant 2010; 46: 27-33.
22. Lucarelli G, Isgrò A, Sodani P, Gaziev J. Hematopoietic Stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med 2012; 2: a 011825.
23. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918-1924.